Exploring CD26−/lo subpopulations of lymphocytes in asthma phenotype and severity: A novel CD4+ T cell subset expressing archetypical granulocyte proteins
Authors:
- Sara Vázquez‐MeraSVSara Vázquez‐Mera
- Laura Martelo‐VidalLMLaura Martelo‐Vidal
- Pablo Miguéns‐SuárezPMPablo Miguéns‐Suárez
- Susana Belén BravoSBSusana Belén Bravo
- Paula Saavedra‐NievesPSPaula Saavedra‐Nieves
- Pilar AriasPAPilar Arias
- Antía Ferreiro‐PosseAFAntía Ferreiro‐Posse
- Juan Vázquez‐LagoJuan Vázquez‐Lago
- Francisco Javier SalgadoFSFrancisco Javier Salgado
- Francisco Javier González‐BarcalaFGFrancisco Javier González‐Barcala
- Juan José Nieto‐FontarigoJNJuan José Nieto‐Fontarigo
Open Access
- 25 September 2024
- Vol. 79 (11) , 3005-3021
Abstract
Background: Asthma pathology may induce changes in naïve/memory lymphocyte proportions assessable through the evaluation of surface CD26 (dipeptidyl peptidase 4/DPP4) levels. Our aim was to investigate the association of asthma phenotype/severity with the relative frequency of CD26−/lo, CD26int and CD26hi subsets within different lymphocyte populations.Methods: The proportion of CD26−/lo, CD26int and CD26hi subsets within CD4+ effector T cells (Teff), total CD4− lymphocytes, γδ‐T cells, NK cells and NKT cells was measured in peripheral blood samples from healthy (N = 30) and asthma (N = 119) donors with different phenotypes/severities by flow cytometry. We performed K‐means clustering analysis and further characterised the CD4+CD26−/lo Teff cell subset by LC–MS/MS and immunofluorescence.Results: Cluster analysis including clinical and flow cytometry data resulted in four groups, two of them with opposite inflammatory profiles (neutrophilic vs. eosinophilic). Neutrophilic asthma presented reduced CD4−CD26hi cells, which negatively correlated with systemic inflammation. Eosinophilic asthma displayed a general expansion of CD26−/lo subsets. Specifically, CD4+CD26−/lo Teff expansion was confirmed in asthma, especially in atopic patients. Proteomic characterisation of this subset with a TEM/TEMRA phenotype revealed upregulated levels of innate (e.g. MPO and RNASE2) and cytoskeleton/extracellular matrix (e.g. MMP9 and ACTN1) proteins. Immunofluorescence assays confirmed the presence of atypical proteins for CD4+ T cells, and an enrichment in ‘flower‐like’ nuclei and MMP9/RNASE2 levels in CD4+CD26−/lo Teff compared to CD4+ T lymphocytes.Conclusion: There is an association between CD26 levels in different lymphocyte subsets and asthma phenotype/severity. CD4+CD26−/loTEMRA cells expressing innate proteins specific to eosinophils/neutrophils could be determinant in sustaining long‐term inflammation in adult allergic asthma.Keywords
Funding Information
- Instituto de Salud Carlos III
- Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033(RYC2021‐032676‐I))
This publication has 63 references indexed in Scilit:
- Circulating clover‐leaf cells presenting in acute‐type adult T‐cell leukemia‐lymphomaeJHaem, 2022
- SWATH-MS Protocols in Human Diseases2021
- γδ T Lymphocytes in Asthma: a Complicated PictureArchivum Immunologiae et Therapiae Experimentalis, 2021
- Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotypingCytometry Part B: Clinical Cytometry, 2020
- CD26 and Asthma: a Comprehensive ReviewClinical Reviews in Allergy & Immunology, 2016
- Clinical significance of serum Th1‐, Th2‐ and regulatory T cells‐associated cytokines in adult T‐cell leukemia/lymphoma: High interleukin‐5 and ‐10 levels are significant unfavorable prognostic factorsInternational Journal of Cancer, 2006
- Eosinophilia associated with adult t-cell leukemia: Role of interleukin 5 and granulocyte-macrophage colony-stimulating factorAmerican Journal of Hematology, 1998
- Expression of CD26/dipeptidyl peptidase IV in adult T cell leukemia/lymphoma (ATLL)Leukemia Research, 1996
- Frequency of eosinophilia in adult T-cell leukemia/lymphomaCancer, 1992
- Finding Groups in Data1990